MAPK8 and hepatocellular carcinoma: In this study, we reveal that CFZ activates ER stress and JNK/p38 MAPK signaling to suppress cell proliferation, migration, and invasion while inducing apoptosis of HCC cells, which suggests that CFZ may be a potential therapeutic agent for treating and improving the outcome of patients with HCC.